Based on a unified board of 300 KR·US·JP stocks · updated July 16, 2026 at 02:07 AM KST
CHUGAI PHARMACEUTICAL CO is 1.7× Samsung Biologics
As of July 16, 2026 at 02:07 AM KST, CHUGAI PHARMACEUTICAL CO (4519.T) has a market cap of $72B — #127 worldwide — while Samsung Biologics (207940.KS) stands at $43B, ranking #147. The gap is $29B; Samsung Biologics is 59.6% the size of CHUGAI PHARMACEUTICAL CO.
CHUGAI PHARMACEUTICAL CO ranks #24 among Japan stocks (Healthcare), and Samsung Biologics ranks #9 among Korea stocks (Healthcare).
If Samsung Biologics reached CHUGAI PHARMACEUTICAL CO's market cap, its share price would need to go from $929.55 to $1559.53 (about +68%).